- A new study funded by the National Institutes of Health found that the controversial hydroxychloroquine drug didn’t help coronavirus patients.
- The study included nearly 1,400 patients and concluded the anti-malaria drug wasn’t effective against the virus.
- This was an observational study, meaning the researchers did not control the actual therapy of patients, and they didn’t compare hydroxychloroquine to a placebo.
- Visit BGR’s homepage for more stories.
Touted as one of the most promising drugs in the fight against COVID-19, hydroxychloroquine is receiving increased resistance based on data that indicates the anti-malaria drug isn’t helpful against the novel coronavirus. Hydroxychloroquine and chloroquine received plenty of coverage in March for a variety of reasons. Anecdotal evidence showed that some COVID-19 patients recovered after being given the drug. But one person died ingesting a substance that sounded like the drug, and others poisoned themselves with similar-sounding products.
Studies that followed indicated the drug can have severe adverse effects on the heart that can be fatal, prompting researchers in Brazil and France to stop their studies. Results from the biggest hydroxychloroquine study yet come from US-funded research, and they indicate the medicine isn’t helpful in COVID-19 therapy.
Today’s Top Deals
- Today’s best deals: Best-selling face masks and hand sanitizer, $22 earphones, $100 off Bose 700, Amazon devices, more
- Here are this week’s 5 best-selling electronics devices on Amazon
- Everyone’s swarming Amazon for these coronavirus face masks
Trending Right Now:
- Scientists have developed antibodies that can kill coronavirus
- Here’s why coronavirus is still spreading even though most of us are stuck at home
- This startling discovery might protect men from coronavirus
US study says hydroxychloroquine doesn’t help coronavirus patients originally appeared on BGR.com on Fri, 8 May 2020 at 18:06:26 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report